Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes

Item
http://www.wikidata.org/entity/Q28603888
Progress and prospects for L2-based human papillomavirus vaccinesBroad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.Developments in L2-based human papillomavirus (HPV) vaccines.Recent advances in preclinical model systems for papillomaviruses.Immunization of mice by a multimeric L2-based linear epitope (17-36) from HPV type 16/18 induced cross reactive neutralizing antibodies.PhiXing-it, displaying foreign peptides on bacteriophage ΦX174.Human papillomavirus 16L1-58L2 chimeric virus-like particles elicit durable neutralizing antibody responses against a broad-spectrum of human papillomavirus types.Broadly neutralizing antiviral responses induced by a single-molecule HPV vaccine based on thermostable thioredoxin-L2 multiepitope nanoparticles.Antibody Competition Reveals Surface Location of HPV L2 Minor Capsid Protein Residues 17-36.A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice.
P2860

Durable immunity to oncogenic human papillomaviruses elicited by adjuvanted recombinant Adeno-associated virus-like particle immunogen displaying L2 17-36 epitopes

Item
http://www.wikidata.org/entity/Q28603888
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@ast
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@en
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@nl
type
label
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@ast
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@en
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@nl
prefLabel
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@ast
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@en
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Durable immunity to oncogenic ...... n displaying L2 17-36 epitopes
@en
P2093
P2860
P304
P31
P356
10.1016/J.VACCINE.2015.09.005
P407
P433
P478
P50
P577
P698
P921
P932